Canopy Growth (CGC) Enterprise Value (2017 - 2025)
Canopy Growth's (CGC) quarterly Enterprise Value came in at -$148.7 million in Q4 2025, down 66.2% year-on-year from -$439.9 million in Q4 2024, and down 51.46% quarter-over-quarter from -$98.2 million in Q3 2025.
Canopy Growth (CGC) Enterprise Value (2017 - 2025) Analysis & Trends
Canopy Growth has disclosed Enterprise Value across 9 years of filings, most recently posting -$148.7 million for Q4 2025.
- Enterprise Value for Q4 2025 came in at -$148.7 million, down 66.2% year-over-year; the trailing twelve-month figure through Dec 2025 was -$148.7 million (down 66.2% YoY), and the FY2025 annual result was -$83.7 million, down 28.31% from the prior year.
- Enterprise Value came in at -$148.7 million for Q4 2025 at Canopy Growth, down from -$98.2 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$12.7 million in Q2 2025 to a low of -$932.6 million in Q2 2022.
- The 5-year median for Enterprise Value is -$305.5 million (2023), against an average of -$361.6 million.
- Across the five-year window, Enterprise Value slumped 101.39% in 2022 and surged 91.11% in 2025, its largest moves.
- Canopy Growth's Enterprise Value stood at -$494.4 million in 2021, then retreated by 17.46% to -$580.7 million in 2022, then surged by 76.47% to -$136.7 million in 2023, then jumped by 34.53% to -$89.5 million in 2024, then tumbled by 66.2% to -$148.7 million in 2025.
- The last three Enterprise Value figures came in at -$148.7 million (Q4 2025), -$98.2 million (Q3 2025), and -$12.7 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | -3.74 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | -1.94 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | -2.15 Bn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | -77.77 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | -1.32 Bn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | -428.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -511.86 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | -498.58 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -750.88 Mn |
| 10 | Canopy Growth | 11.38 Mn | -137.31 Mn | 15.39 Mn | -148.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -148.69 Mn |
| Sep 30, 2025 | -98.18 Mn |
| Jun 30, 2025 | -12.67 Mn |
| Mar 31, 2025 | -83.69 Mn |
| Dec 31, 2024 | -89.47 Mn |
| Sep 30, 2024 | -172.93 Mn |
| Jun 30, 2024 | -142.52 Mn |
| Mar 31, 2024 | -65.23 Mn |
| Dec 31, 2023 | -136.65 Mn |
| Sep 30, 2023 | -187.10 Mn |
| Jun 30, 2023 | -423.96 Mn |
| Mar 31, 2023 | -570.77 Mn |
| Dec 31, 2022 | -580.71 Mn |
| Sep 30, 2022 | -572.30 Mn |
| Jun 30, 2022 | -932.55 Mn |
| Mar 31, 2022 | -596.62 Mn |
| Dec 31, 2021 | -494.38 Mn |
| Sep 30, 2021 | -647.13 Mn |
| Jun 30, 2021 | -463.06 Mn |
| Mar 31, 2021 | -814.34 Mn |